This week, Neal K. Shah joins the show to talk about the years-long caregiving journey that reshaped his life, his career, and ultimately the creation of CareYaya Health Technologies. He shares how managing a billion-dollar hedge fund became incompatible with the reality of his grandfather’s dementia care and his wife’s life-threatening illness, and how those experiences exposed the true weight carried by family caregivers. 🎧 This episode traces Neal Shah’s shift from hedge fund leader to full-time caregiver and founder of CareYaya. He shares what the home-care system really looks like for families and how a tech-enabled student workforce is changing access to reliable support. 04:52 Early hedge fund career and the shift triggered by family illness 07:50 The cost, quality gaps, and hidden burdens families face 10:49 Recognizing the scale of unmet needs for aging and chronic illness 18:54 The idea that became CareYaya: a structured way to connect families with healthcare-bound students 21:35 Building the MVP with local universities and early explosive demand 25:04 How finding the right technical co-founder shaped the company’s trajectory 28:36 How new ideas emerged, including AI tools for claims management 32:20 Why younger engineers outperform in an AI-first world 40:35 Could Medicare eventually reimburse companion-level care? 41:20 How this could scale into a multibillion-dollar platform 44:49 The political torque keeping insurance reform stagnant 💡 Who Should Listen Healthcare innovators, MedTech founders, clinicians who support aging or chronically ill populations, caregivers, and anyone building technology to solve real structural problems in the healthcare system. About Neal Neal K. Shah is the CEO of CareYaya Health Technologies, a social enterprise and research lab advancing health equity for aging populations, and recognized by LinkedIn as one of America’s Top 50 Startups in 2024. He also serves as Chairman of Counterforce Health, an AI platform for navigating health insurance claim denials, and Principal Investigator on multiple federal innovation grants. Shah is also the author of “Insured to Death: How Health Insurance Screws Over Americans - And How We Take It Back”, a #1 bestseller in Health Policy. Shah holds degrees in economics and philosophy from University of Pennsylvania. Prior to CareYaya, Shah managed a $250 million hedge fund. His pivot to healthcare came after deeply personal experiences as a caregiver, which inspired a mission-driven focus on transforming care delivery through tech. Today, Shah is building CareYaya into a national leader in care innovation. Shah’s work has been supported by the NIH, Johns Hopkins AITC, AARP, and Harvard Innovation Labs. He also regularly contributes to CNBC, US News & World Report, Barron’s, STAT, Neurology Live, and Medical Economics. Connect with Neal 💼 LinkedIn: Neal K. Shah 📲 Instagram: @nealkshah 🎶 TikTok: @nealkshah 📘Substack: nealkshah.substack.com 💼 LinkedIn: Counterforce Health 📲 Instagram: @counterforcehealth 🎶 TikTok: @counterforcehealth About CareYaya Health Technologies CareYaya is a mission-driven social enterprise supported by dozens of interns and volunteers nationwide. This provides affordable care for thousands of families, introduces tens of thousands of energetic individuals into the care workforce, and impacts millions by investing in the healthcare professionals of tomorrow. Together, they’re changing elder care by connecting families with compassionate, motivated college students from top universities. Learn more about CareYaya 🌐 Website: careyaya.org 💼 LinkedIn: @Careyaya 📲 Instagram: @wearecareyaya 🎶 TikTok: @wearecareyaya Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this episode gave you a new take on caregiving or the gaps in home care, share it with someone who’d value it. And if you’re enjoying Life of Flow, a quick review helps others find conversations like this!

En este episodio de Life of Flow Podcast, conversamos con el Dr. Pedro G. R. Teixeira, M.D., cirujano vascular y de trauma en UT Health Austin y Ascension Seton. Juntos exploramos su recorrido desde Belo Horizonte hasta liderar una división académica en Austin, y cómo esa trayectoria marcó su visión sobre formación, adaptabilidad, trabajo en equipo y liderazgo quirúrgico. ❗️Este episodio, grabado originalmente en inglés y ahora doblado al español, captura una conversación honesta sobre liderazgo médico, trabajo interdisciplinario y el futuro de la atención basada en valor. English Version of the Episode 👉youtube.com/watch?v=x5Jl0FEmnqQ 01:05 Nacer y formarse en Belo Horizonte: primeros pasos en trauma 04:00 Llegar a EE. UU. como adjunto y descubrir un sistema quirúrgico completamente distinto 07:10 Repetir la residencia desde cero: humildad, ego y aprendizaje 10:15 Barreras culturales: acrónimos, lenguaje quirúrgico y reinvención diaria 13:40 El valor real del cirujano más allá del título y la jerarquía 18:00 Descubrir la cirugía vascular y la emoción de volver a ser principiante 21:05 Por qué mantiene guardias de trauma: compromiso social y responsabilidad 24:00 El cirujano vascular como soporte esencial en casos complejos 33:05 El proceso inesperado de convertirse en jefe de división 37:00 Su visión para transformar la atención vascular en Austin y construir una cultura colaborativa 💡¿Quién debería escuchar este episodio? Médicos en formación, cirujanos vasculares y de trauma, líderes clínicos, profesionales internacionales interesados en entrenar en EE. UU. y cualquier persona que trabaje en estructuras académicas o equipos quirúrgicos de alto rendimiento. Sobre Dr. Pedro G. R. Teixeira, MD Pedro G. R. Teixeira, MD, es un cirujano vascular certificado que ejerce en el Institute for Cardiovascular Health, una colaboración entre Ascension y UT Health Austin. Está especializado en el manejo integral de enfermedades arteriales y venosas, y colabora con múltiples especialidades quirúrgicas en procedimientos complejos que requieren exposición y reconstrucción vascular. Es profesor en el Departamento de Cirugía Cardiovascular y Torácica de Dell Medical School en la Universidad de Texas en Austin. Se formó inicialmente en Brasil y completó residencia en cirugía general, una beca en cirugía vascular y otra en cuidados críticos quirúrgicos en la Universidad del Sur de California. Su investigación se centra en el cruce entre trauma y cirugía vascular, con más de 150 publicaciones revisadas por pares, y ha contribuido de manera decisiva a la educación quirúrgica y al desarrollo de principios modernos de control de hemorragias y técnicas mínimamente invasivas. Es coeditor de Vascular Injury: Endovascular and Open Surgical Management, presidente de la Texas Society for Vascular and Endovascular Surgery y miembro activo de múltiples organizaciones quirúrgicas nacionales e internacionales. 🌐 UT Health Austin: Pedro G. R. Teixeira, MD Sigue a Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast ¿Conoces a alguien que debería escuchar esta conversación? 🎧 Envíale este episodio y ayúdanos a que más personas accedan a estas historias y aprendizajes.

In this episode, we sit down with Shane Gleason, Chief Commercial Officer at InspireMD, to talk about what it means to bring a new carotid stent to market at a time when treatment options are evolving. Shane shares how his two decades in the vascular space shaped the way he evaluates timing, team, and technology, and why those factors mattered when he decided to join InspireMD. He also walks through the details of their flexible open-celled nitinol stent with a finely woven PET mesh, explaining what it does, how it behaves, and why physicians have responded so strongly to it. The conversation moves from device design to clinical trials, commercial planning, and the changing landscape following CMS’s expanded coverage for carotid stenting. 🎧 This episode goes inside the work behind developing and launching a new carotid stent, and how the right timing, the right team, and a device designed for lasting protection can shift practice. 04:50 Why carotid procedures still make him sweat after hundreds of cases 06:14 What lasting protection means and why post-procedure events matter 07:01 Dual antiplatelet therapy and how the PET mesh behaves in the vessel 07:33 Showing the stent on camera and explaining the woven PET mesh 08:36 TCAR, transfemoral approaches, and what current trials are studying 11:12 How Shane’s team is approaching commercialization in the U.S. 12:22 Why the procedure attracts experienced reps and how they support cases 14:17 Why physicians say they’ve “been waiting for this for 20 years” 16:02 What it means to be the only company singularly focused on carotid disease 💡 Who Should Listen This episode is for vascular surgeons, neurointerventionalists, industry professionals supporting carotid interventions, and anyone following the current shift in carotid disease treatment and device innovation. About Shane Mr. Gleason has over 20 years of experience in the medical device industry leading clinical and commercial operations in both public and privately held companies. Prior to joining InspireMD, he served as Vice President of Sales, Vascular Interventions at Surmodics, a medical device company focused on addressing unmet clinical needs in intravascular medicine. Prior to Surmodics, Mr. Gleason served in a variety of leadership roles in the interventional medical device space, to include Senior Director, US Transcatheter Heart Valves Marketing for Edwards Lifesciences, a developer of artificial heart valve technologies; Chief Commercial Officer of Nuvaira, a privately held developer of therapies that preserve patient lung health; and Vice President of Sales roles with both Cordis, a Cardinal Health company, and TriVascular Technologies, now part of Endologix. He began his medical device career with a variety of progressive leadership roles at Abbott Vascular, where he launched the second FDA approved carotid stent system. Mr. Gleason received his B.S. in Engineering Science and Mechanics from Virginia Polytechnic Institute and State University and his M.B.A. from the University of Maryland’s Smith School of Business. Connect with Shane 💼 LinkedIn: Shane Gleason 🌐 InspireMD: inspiremd.com/team/shane-gleason/ About InspireMD InspireMD is a global carotid-focused company dedicated to helping prevent stroke, save lives, and give physicians and patients the confidence to choose carotid stenting without compromise. Based in Miami, the company is leading an international effort to advance carotid artery intervention through thoughtful engineering and a commitment to innovation. Their mission centers on one idea: stroke prevention is the blueprint, not an afterthought. With a focus on smarter design and strong clinical data, InspireMD aims to protect against carotid plaque prolapse and support physicians with a solution built for safety and clarity. CGuard® Prime, the company’s flagship product, is a next-generation carotid stent featuring a dual-layer design with a finely woven MicroNet™ mesh. It is the only FDA-approved mesh-covered carotid stent and was designed to offer a new layer of defense against the risk of plaque prolapse and embolization. In pivotal studies, CGuard Prime demonstrated the lowest independently adjudicated 30-day and 1-year major adverse event rates reported to date. Learn more about InspireMD 🌐 Website: inspiremd.com/ Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this episode gave you a new perspective on carotid disease treatment, device innovation, or the future of carotid stenting, share it with a colleague who would value the conversation. And if you’ve been enjoying Life of Flow, leaving a short review helps more listeners find stories like this one.